Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）.
Clinical trial NCT06375486 · UNKNOWN
Trial details
- NCT number
- NCT06375486
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-14
- Primary completion
- 2025-03-14
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.